Medicinova MNOV
NASDAQ MNOV
$1.41 +0.01 (+0.71%)
At close: Nov 11, 2026 · 4:00 PM EST

Medicinova (MNOV) Gains from Sales and Divestitures (2009 - 2024)

Updated

Medicinova (MNOV) reported Gains from Sales and Divestitures of -$1.00 for Q4 2024, compared with -$101.00 a year earlier.

Analysis

Medicinova (MNOV) Gains from Sales and Divestitures (2009 - 2024) Analysis & Trends

For FY2024, Medicinova posted Gains from Sales and Divestitures of $198.00.

  • By year, Gains from Sales and Divestitures came in at -$472.00 in FY2023 and -$286.00 in FY2021.
  • The Q4 2024 figure ranks as the highest quarterly Gains from Sales and Divestitures since Q1 2013.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn
10 Medicinova 68.91 Mn -47.24 Mn 317,759.00
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2024 -1.00
Dec 31, 2023 -101.00
Dec 31, 2013 -493.00
Mar 31, 2013 4,800.00
Dec 31, 2012 -11,460.00
Mar 31, 2012 10,637.00
Dec 31, 2011 10,637.00
Jun 30, 2011 -10,637.00
Mar 31, 2011 10,637.00
Dec 31, 2010 3,386.00
Jun 30, 2010 -4,052.00
Mar 31, 2010 2,026.00
Dec 31, 2009 -23,055.00
API Access

Medicinova Gains from Sales and Divestitures API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=gains-from-sales-and-divestitures&ticker=MNOV&period=max&api_key=YOUR_API_KEY